11.12.2012 Views

Sabato 27 ottobre 2012 - Pacini Editore

Sabato 27 ottobre 2012 - Pacini Editore

Sabato 27 ottobre 2012 - Pacini Editore

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

394<br />

Immunoreactions were revealed us-<br />

Fig. 1.<br />

ing a streptavidin-biotin enhanced<br />

immunoperoxidase technique (Super<br />

Sensitive MultiLink, Menarini, Florence,<br />

Italy) in an automated autostainer.<br />

Receiver Operative Curve<br />

(ROC) analysis was adopted for<br />

optimal cut-off values. Evaluation<br />

of the immunohistochemical results,<br />

blinded to all patient data, was performed<br />

independently and in blinded<br />

manner by two investigators (MM<br />

and FN). Statistical analyses: Multiple<br />

Correspondence Analysis (MCA)<br />

was used to identify sub-groups of<br />

BC patients with different prognosis,<br />

while uni-and multivariate Cox<br />

regression analyses were applied to<br />

determine the impact of parameters<br />

identified by MCA on 10-yrs Disease<br />

Free Survival (DFS), together<br />

with clinico-pathological features.<br />

Results. In our series of 133 BC<br />

patients (median follow-up of 107<br />

months) the MCA analysis (Fig. 1)<br />

demonstrates the contrast between<br />

high Ki67/p53+/p-Akt+/PI3K+/<br />

HER2+ (Adverse Biologic Factors,<br />

ABF) and presence of relapse (upper<br />

right quadrant) vs low Ki67/<br />

p53–/p-Akt–/PI3K–/HER2– BC and<br />

no relapse (lower left quadrant).<br />

Therefore, this statistical approach Fig. 2.<br />

may define an Unfavorable Biologic<br />

Profile (UBP) associated to disease<br />

progression considering the presence/absence<br />

of at least 3 variables<br />

out of the 5 selected as discriminative<br />

power, (UBP≥3 ABF) and a<br />

Favourable Biologic Profile (FBP

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!